Based on the Marlowe plc stock forecast from 1 analysts, the average analyst target price for Marlowe plc is GBX 710.00 over the next 12 months. Marlowe plc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Marlowe plc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Marlowe plc’s stock price was GBX 524.00. Marlowe plc’s stock price has changed by +3.56% over the past week, +2.34% over the past month and +0.77% over the last year.
No recent analyst target price found for Marlowe plc
No recent average analyst rating found for Marlowe plc
Company Overview Marlowe plc
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services. In addition, the company offers employment law advice, employee contracts and handbooks, case management software, organisational change support, HR consultation and dispute support, and HR audit services. Further, it provides strategy, advisory, risk, compliance, performance and attendance, wellbeing, and musculoskeletal services. Additionally, the company offers fire risk assessments, installation of fire systems, monitoring and maintenance, design and installation of security systems, security monitoring solutions, and technical support services. Furthermore, it provides water treatment, air hygiene compliance, wastewater and effluent treatment, ventilation hygiene, asbestos consultancy, and water engineering services. The company serves office complexes, streets, leisure facilities, industrial estates, SMEs, local corporates and authorities, other facilities, property management providers, NHS trusts, and FTSE companies. Marlowe plc was founded in 2015 and is headquartered in London, the United Kingdom. Read Less
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, c...Read More
Frequently Asked Questions About Marlowe plc (MRL:LSE) Stock
Based on ratings from 1 analysts Marlowe plc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on MRL:LSE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for MRL:LSE is GBX 710.00 over the next 12 months. The maximum analyst target price is GBX 710 while the minimum anlayst target price is GBX 710.
Unfortunately we do not have enough data on MRL:LSE's stock to indicate if its overvalued.
The last closing price of MRL:LSE's stock was GBX 524.00.
The most recent market capitalization for MRL:LSE is GBX 0.49B.
Based on targets from 1 analysts, the average taret price for MRL:LSE is projected at GBX 710.00 over the next 12 months.
This means that MRL:LSE's stock price may go up by +35.50% over the next 12 months.
We can't find any ETFs which contains Marlowe plc's stock.
As per our most recent records Marlowe plc has 4,972 Employees.
Marlowe plc's registered address is 20 Grosvenor Place, London, United Kingdom, SW1X 7HN.
You can get more information about it from Marlowe plc's website at https://www.marloweplc.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MRL:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
